Why the study?
Does low-dose aspirin prevent preeclampsia and adverse maternal and perinatal health outcomes in high-risk asymptomatic pregnant women?
Does low-dose aspirin prevent preeclampsia and adverse maternal and perinatal health outcomes in high-risk asymptomatic pregnant women?
The USPSTF recommends low-dose aspirin (81 mg/d) starting after 12 weeks of gestation for pregnant women at high risk for preeclampsia to prevent morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Supports low-dose aspirin initiation after 12 weeks in high-risk pregnancies; confirms benefit and extends USPSTF guidance for maternal-perinatal outcomes.
Michael Lefevre (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: